Susquehanna International Group’s Milestone Pharmaceuticals MIST Stock Holding History

Susquehanna International Group’s Portfolio MIST Stock Details MIST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$131K	Sell	110,100 -422,800	-79%	-$740K	﹤0.01%	12140
2025 Q4	$1.08M	Buy	532,900 +325,900	+157%	+$702K	﹤0.01%	7018
2025 Q3	$414K	Buy	207,000 +187,200	+945%	+$329K	﹤0.01%	9401
2025 Q2	$38.4K	Sell	19,800 -12,300	-38%	-$16.4K	﹤0.01%	12185
2025 Q1	$25.7K	Buy	32,100 +15,100	+89%	+$30K	﹤0.01%	12053
2024 Q4	$40.1K	Buy	+17,000	New	+$29.2K	﹤0.01%	11761
2022 Q4	–	Sell	-239,000	Closed	-$2.2M	–	13184
2022 Q3	$2.2M	Buy	239,000 +229,000	+2,290%	+$1.74M	﹤0.01%	4722
2022 Q2	$59K	Buy	+10,000	New	+$61.4K	﹤0.01%	11874
2021 Q2	–	Sell	-13,100	Closed	-$76K	–	12990
2021 Q1	$76K	Buy	+13,100	New	+$95.9K	﹤0.01%	11949

Other funds holding MIST

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

PBM

Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

LPC

Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

Susquehanna International Group's MIST Position: Q1 2026 in Review

Susquehanna International Group reduced its Milestone Pharmaceuticals (MIST) stake by 19% in Q1 2026, selling an estimated $218K and leaving 519,046 shares worth $618K. The position accounts for ﹤0.01% of the portfolio, ranked #9111.

Susquehanna International Group first reported a position in MIST in Q4 2020 and has held it in 12 quarters since. The position peaked at $1.3M in Q4 2025. 86 funds tracked by Wall St. Rank hold MIST as of Q1 2026.

Susquehanna International Group held 519,046 shares of Milestone Pharmaceuticals worth $618K as of Q1 2026.
Susquehanna International Group sold 124,254 Milestone Pharmaceuticals shares in Q1 2026, an estimated $218K.
Milestone Pharmaceuticals made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #9111 holding.
Susquehanna International Group first reported a position in Milestone Pharmaceuticals in Q4 2020 and has held it in 12 quarters since.
Susquehanna International Group's Milestone Pharmaceuticals position peaked at $1.3M in Q4 2025.
86 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.